In contrast, the current study found TfR1 protein levels in RCC primary tumors, and particularly the ccRCC subtype, to be strongly associated with adverse RCC pathology, including primary tumor size, stage, grade, number and sarcomatoid dedifferentiation. The gene discussed is TFRC; the disease is nonpapillary renal cell carcinoma.